Pharmidex hosts annual Japanese exchange students
November 3, 2015

Student visit from Meiji Pharmaceutical University (Japan) and the Department of Pharmacy, University of Hertfordshire (UK) to Pharmidex Facility.

Pharmidex has the pleasure of continuing to host Japanese exchange students.



Yoko Haraguchi and Soko Yoshino visited Pharmidex as part of their academic exchange program between Meiji Pharmaceutical University (Japan) and the Department of Pharmacy, University of Hertfordshire (UK). The Pharmidex team had the pleasure of welcoming a new set of students from Japan on a tour of our facilities and experiencing what it is like to work in SME within the Pharmaceutical sector in the European Union.


Business development manager Dr Martin Barrett was once again pleased to continue the company’s collaborations with Meji Pharmaceutical University and Department of Pharmacy, University of Hertfordshire, furthermore as a company we very much look forward to fostering closer links with all interested parties on mutually beneficial projects. Dr Nkiruka Umaru (Nikkie) of Department of Pharmacy, school of life and medical sciences at University of Hertfordshire also added that University of Hertfordshire is delighted that our Japanese visitors had the opportunity to learn more about the dynamic biotechnology SMEs in UK.

Thanks to our interns from City St George’s, University of London

June 19, 2026
A big thank you to our interns from City St George’s, University of London and heir fantastic contribution to Pharmidex over the past few months. They have supported scientific projects across the business, developed valuable technical skills and gained hands-on experience within a CRO environment. Their contribution has extended beyond the laboratory, helping with our website, marketing materials, conference preparation and business development activities. Science drives success, but communicating that science effectively is just as important. Our interns have helped us do both. Thank you for your hard work, enthusiasm, and dedication. We wish you every success in the next stage of your careers.

Pharmidex at the "Creative Disruption Forum: Modern Drug Discovery in Cambridge."

June 17, 2026
On 18 June, our COO, Ash Alavijeh , will join an industry panel discussing: "What are the advantages and disadvantages of working with UK-based Discovery CROs?" The session will explore the value of UK CROs in supporting innovation, protecting IP, accessing scientific expertise and accelerating drug discovery programmes. 📅 18 June 2025 📍 Cambridge 🕒 Panel Session: 12:20–12:45 We look forward to connecting with colleagues, collaborators, and innovators from across the life sciences community.

Congratulate Dr Mansoor Chishty as Director of DMPK at Pharmidex

June 16, 2026
This well-deserved appointment marks an important milestone in a remarkable career spanning more than 22 years at Pharmidex . Over the years, Dr Chishty has made a significant contribution to the growth of our DMPK capabilities, applying his extensive expertise in Drug Metabolism and Pharmacokinetics to support successful drug discovery and development programmes for clients worldwide. His scientific leadership, dedication and commitment to excellence have been instrumental in strengthening our services and supporting the continued success of Pharmidex . As we continue to grow and support innovative biopharmaceutical companies, we look forward to the impact Dr Chishty will make in this new role. Please join us in congratulating Dr Mansoor Chishty on this achievement and wishing him every success as Director of DMPK.
More Posts